|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 388.90 DKK | +6.49% |
|
+1.43% | +18.95% |
| 08:48pm | Novo's Wegovy pill makes 'encouraging' start in weight-loss race vs Lilly | RE |
| 08:38pm | Novo Nordisk spokesperson says all doses of Wegovy pill are broadly available nationwide for Americans | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- NOVO B Stock
- Consensus Novo Nordisk A/S
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition